Roche: in Goldman Sachs 'conviction list'
(CercleFinance.com) - Goldman Sachs said on Wednesday that it has included Roche in its list of recommended shares ("conviction list"), highlighting its defensive profile in the current market context.
In a report on the European health sector, analysts are now looking for shares whose valuation do not appear to reflect fundamentals following the markets' recent purge.
Goldman has a buy rating on the Roche share, along with a target price of 400 Swiss francs, explains that its growth momentum seems to to be "underestimated" by investors.
More generally, holding Roche shares - whose valuation does not include either its "solid" balance sheet or its comfortable cash flow - seems to to be "well suited" to the current market environment, marked by excess volatility.
At lunchtime on Wednesday, the Roche share is up almost 1% on the Zurich Stock Exchange.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
In a report on the European health sector, analysts are now looking for shares whose valuation do not appear to reflect fundamentals following the markets' recent purge.
Goldman has a buy rating on the Roche share, along with a target price of 400 Swiss francs, explains that its growth momentum seems to to be "underestimated" by investors.
More generally, holding Roche shares - whose valuation does not include either its "solid" balance sheet or its comfortable cash flow - seems to to be "well suited" to the current market environment, marked by excess volatility.
At lunchtime on Wednesday, the Roche share is up almost 1% on the Zurich Stock Exchange.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.